𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Front-line paclitaxel and topotecan chemotherapy in advanced or metastatic non-small-cell lung cancer: a phase II trial

✍ Scribed by G. P. Stathopoulos; C. Katis; D. Tsavdaridis; J. Dimitroulis; D. Karaindros; J. Stathopoulos; E. Dimou


Publisher
Springer
Year
2006
Tongue
English
Weight
217 KB
Volume
58
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Weekly paclitaxel and gemcitabine chemot
✍ Vera Hirsh; Renaud Whittom; Linda Ofiara; Pierre Desjardins; Joseph Ayoub; Danie πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 84 KB πŸ‘ 2 views

## Abstract ## BACKGROUND The current dose‐optimizing Phase II study evaluated the effect of weekly paclitaxel and gemcitabine on the response rate and survival of patients with non‐small cell lung carcinoma (NSCLC) using dose modifications that permitted optimal treatment intensity. ## METHODS